AxoGen, Inc.
AXGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $187,338 | $159,012 | $138,584 | $127,358 |
| % Growth | 17.8% | 14.7% | 8.8% | – |
| Cost of Goods Sold | $45,361 | $37,143 | $29,775 | $22,931 |
| Gross Profit | $141,977 | $121,869 | $108,809 | $104,427 |
| % Margin | 75.8% | 76.6% | 78.5% | 82% |
| R&D Expenses | $27,767 | $27,339 | $25,627 | $24,177 |
| G&A Expenses | $39,036 | $38,412 | $40,906 | $32,338 |
| SG&A Expenses | $117,497 | $115,992 | $112,889 | $105,666 |
| Sales & Mktg Exp. | $78,461 | $77,580 | $71,983 | $73,328 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $145,264 | $143,331 | $138,516 | $129,843 |
| Operating Income | -$3,287 | -$21,462 | -$29,707 | -$25,416 |
| % Margin | -1.8% | -13.5% | -21.4% | -20% |
| Other Income/Exp. Net | -$6,677 | -$254 | $759 | -$1,569 |
| Pre-Tax Income | -$9,964 | -$21,716 | -$28,948 | -$26,985 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9,964 | -$21,716 | -$28,948 | -$26,985 |
| % Margin | -5.3% | -13.7% | -20.9% | -21.2% |
| EPS | -0.23 | -0.51 | -0.69 | -0.65 |
| % Growth | 54.9% | 26.1% | -6.2% | – |
| EPS Diluted | -0.23 | -0.51 | -0.69 | -0.65 |
| Weighted Avg Shares Out | 44,258 | 42,879 | 42,083 | 41,215 |
| Weighted Avg Shares Out Dil | 44,258 | 42,879 | 42,083 | 41,215 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $8,206 | $2,835 | $624 | $1,356 |
| Depreciation & Amortization | $7,837 | $5,553 | $4,853 | $4,741 |
| EBITDA | $6,079 | -$13,328 | -$23,471 | -$20,888 |
| % Margin | 3.2% | -8.4% | -16.9% | -16.4% |